Biotech stocks are lighting up the tape today, with several clinical-stage companies posting double-digit gains on fresh catalysts. From earnings beats to promising trial data and billion-dollar partnerships, investors are rewarding progress across oncology, immunology, and drug delivery platforms. Here’s a quick look at four making the biggest move on Monday: CorMedix, RAPT Therapeutics, Celcuity,











